Guardian Pharmacy Services Hits New 52-Week High at $41.72

Guardian Pharmacy Services, Inc. has reached a significant milestone by hitting a new 52-week high of USD 41.72 on June 5, 2026. This achievement underscores the company's strong performance in the retailing sector, particularly as it navigates the competitive landscape of small-cap stocks. Over the past year, Guardian Pharmacy Services has demonstrated a robust performance, with a notable increase of 24.32% compared to the S&P 500. The company's market capitalization stands at USD 2,163 million, reflecting its position within the small-cap category. Financial metrics reveal a price-to-earnings (P/E) ratio of 41.00, indicating the market's valuation of the company's earnings. Additionally, the stock's price-to-book ratio is recorded at 10.51, suggesting a premium valuation relative to its book value. Despite a dividend yield of 0.00% and a negative return on equity, Guardian Pharmacy Services continues to attract attention with its recent price movements, marking a significant point in its trading history. The stock's previous 52-week low was USD 19.17, highlighting the substantial growth it has experienced over the past year.